OMIA:002256-9615 : Cardiomyopathy and juvenile mortality in Canis lupus familiaris
Categories: Cardiovascular system phene
Possibly relevant human trait(s) and/or gene(s)s (MIM numbers): 613561 (trait) , 610957 (gene)
Links to MONDO diseases: No links.
Mendelian trait/disorder: yes
Mode of inheritance: Autosomal recessive
Considered a defect: yes
Key variant known: yes
Year key variant first reported: 2020
Inheritance: Gurtner et al. (2020): "Pedigree analysis suggested a monogenic autosomal recessive inheritance."
Mapping: Gurtner et al. (2020): "Combined linkage and homozygosity mapping assigned the most likely position of a potential genetic defect to 13 genome segments totaling 82 Mb."
Molecular basis: Gurtner et al. (2020): "The genome of an affected puppy was sequenced and compared to 645 control genomes. Three private protein changing variants were found in the linked and homozygous regions. Targeted genotyping in 96 Belgian Shepherd dogs excluded two of these variants. The remaining variant, YARS2:1054G>A or p.Glu352Lys, was perfectly associated with the phenotype in a cohort of 474 Belgian Shepherd dogs." The variant substitutes a negatively charged glutamate with a positively charged lysine on the surface of the tRNA-binding domain of the mitochondrial tyrosyl-tRNA synthetase 2.
Protein translation requires aminoacyl-tRNAs to deliver the amino acids that are incorporated into nascent peptide chains. Aminoacylation of tRNAs is catalyzed by a set of aminoacyl-tRNA synthetases, which have highly specific recognition sites for their respective amino acids and the corresponding tRNA molecules. Eukaryotes have two tyrosyl-tRNA synthetases, the cytoplasmic tyrosyl-tRNA synthetase 1 (YARS1) and the mitochondrial tyrosyl-tRNA synthetase 2 (YARS2). A mitochondrial translation defect due to the YARS2:p.Glu352Lys represents a plausible cause for juvenile mortality in Belgian Shepherd dogs (Gurtner et al. 2020).
Clinical features: The clinical phenotype is unspecific and variable. In the study of Gurtner et al. (2020), three affected puppies were studied, which all died at 8 weeks of age. A few days prior to death they showed various clinical signs such as vomiting and dyspnea (n = 2) or lethargy and muscle twitching (n = 1) (Gurtner et al. 2020).
Pathology: Cardiomyocytes of affected puppies were swollen and pale, and the sarcoplasm around the nucleus was dispersed by finely granular material (Gurtner et al. 2020). The authors concluded: "The cause of disease and death were likely due to the degenerative changes in the heart, leading to myocardial failure."
Prevalence: Gurtner et al. (2020): "The carrier frequency was 27.2% in the tested Belgian Shepherd dogs"
Breed: Belgian Shepherd.
|Symbol||Description||Species||Chr||Location||OMIA gene details page||Other Links|
|YARS2||tyrosyl-tRNA synthetase 2, mitochondrial||Canis lupus familiaris||27||NC_051831.1 (16320190..16347401)||YARS2||Homologene, Ensembl , NCBI gene|
By default, variants are sorted chronologically by year of publication, to provide a historical perspective.
Readers can re-sort on any column by clicking on the column header. Click it again to sort in a descending
order. To create a multiple-field sort, hold down Shift while clicking on the second, third etc relevant column
WARNING! Inclusion of a variant in this table does not automatically mean that it should be used for DNA testing. Anyone contemplating the use of any of these variants for DNA testing should examine critically the relevant evidence (especially in breeds other than the breed in which the variant was first described). If it is decided to proceed, the location and orientation of the variant sequence should be checked very carefully.
Since October 2021, OMIA includes a semiautomated lift-over pipeline to facilitate updates of genomic positions to a recent reference genome position. These changes to genomic positions are not always reflected in the ‘acknowledgements’ or ‘verbal description’ fields in this table.
|OMIA Variant ID||Breed(s)||Variant Phenotype||Gene||Allele||Type of Variant||Source of Genetic Variant||Reference Sequence||Chr.||g. or m.||c. or n.||p.||Verbal Description||EVA ID||Inferred EVA rsID||Year Published||PubMed ID(s)||Acknowledgements|
|1172||Belgian Shepherd||Cardiomyopathy and juvenile mortality||YARS2||missense||Naturally occurring variant||CanFam3.1||27||g.16157324G>A||c.1054G>A||p.(E352K)||"XM_543740.6:c.1054G>A . . . XP_543740.1:p.(Glu352Lys)" (Gurtner et al. (2020)||2020||32183361|
|2020||Gurtner, C., Hug, P., Kleiter, M., Köhler, K., Dietschi, E., Jagannathan, V., Leeb, T. :|
|<i>YARS2</i> Missense Variant in Belgian Shepherd Dogs with Cardiomyopathy and Juvenile Mortality. Genes (Basel) 11:, 2020. Pubmed reference: 32183361 . DOI: 10.3390/genes11030313.|
- Changed by Frank Nicholas on 23 Mar 2020
- Created by Frank Nicholas on 23 Mar 2020
- Changed by Tosso Leeb on 24 Mar 2020